Lung Cancer Drugs
Get an ideas about the lung cancer treatment drugs, here we provide only information about drugs not to advice them to take without proper doctor guideline. For information about lung cancer drugs browse.
New Study Identifies Drug to Boost Lung Cancer Survival Rates
October 5, 2020
Comments Off on New Study Identifies Drug to Boost Lung Cancer Survival Rates
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is [...]
Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk
September 21, 2020
Comments Off on Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk
The combined use of aspirin, statins and metformin is associated with reduced risk of lung cancer, according to a study published in the Journal of Thoracic [...]
NICE now recommends AstraZeneca’s Tagrisso for Lung Cancer Treatment
September 14, 2020
Comments Off on NICE now recommends AstraZeneca’s Tagrisso for Lung Cancer Treatment
The National Institute of Health and Care Excellence (NICE) has announced the recommendation of Tagrisso (osimertinib) for routine use in two new lung cancer [...]
FDA Approves Gavreto for Metastatic Non-Small Cell Lung Cancer
September 7, 2020
Comments Off on FDA Approves Gavreto for Metastatic Non-Small Cell Lung Cancer
The Food and Drug Administration (FDA) has approved Gavreto (pralsetinib) for treatment of patients with metastatic non-small cell lung cancer (NSCLC). [...]
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
June 1, 2020
Comments Off on Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]
U.S. FDA Gives Nod To Bristol-Myers Combo Therapy For Lung Cancer
May 18, 2020
Comments Off on U.S. FDA Gives Nod To Bristol-Myers Combo Therapy For Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases. Lung cancer patients in advanced stages of the disease have received a new [...]
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
May 11, 2020
Comments Off on FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]
Nintedanib for Treatment of Advanced Lung Cancer
November 25, 2019
Comments Off on Nintedanib for Treatment of Advanced Lung Cancer
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. [...]